Cargando…
Role for Cystatin C–Based Risk Stratification for Patients After Acute Coronary Syndrome in the Era of High Sensitivity Cardiac Troponin Assays
Autores principales: | Latta, Federica, de Filippi, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474958/ https://www.ncbi.nlm.nih.gov/pubmed/30371292 http://dx.doi.org/10.1161/JAHA.118.010589 |
Ejemplares similares
-
Cystatin C in the prognostic stratification of patients with an acute coronary syndrome
por: Lago, A Lopez, et al.
Publicado: (2007) -
Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome
por: Correa, Simon, et al.
Publicado: (2018) -
Risk Stratification Using High-Sensitivity Cardiac Troponin T in Patients With Suspected Acute Coronary Syndrome
por: Chapman, Andrew R., et al.
Publicado: (2020) -
High-sensitivity cardiac troponin I assays in the diagnosis of acute myocardial infarction
por: Chapman, Andrew R, et al.
Publicado: (2017) -
Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
por: Eggers, K. M., et al.
Publicado: (2017)